UY30594A1 - Marcacion radioactiva por fluoracion de aziridinas - Google Patents

Marcacion radioactiva por fluoracion de aziridinas

Info

Publication number
UY30594A1
UY30594A1 UY30594A UY30594A UY30594A1 UY 30594 A1 UY30594 A1 UY 30594A1 UY 30594 A UY30594 A UY 30594A UY 30594 A UY30594 A UY 30594A UY 30594 A1 UY30594 A1 UY 30594A1
Authority
UY
Uruguay
Prior art keywords
fluoration
aziridines
dialing
radioactive
labeled
Prior art date
Application number
UY30594A
Other languages
English (en)
Inventor
Jessica Becaud
Linjing Mu
Ulrike Voigtmann
Keith Graham
Timo Stellfeld
Ananth Srinivasan
Thomas Brumby
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07090001A external-priority patent/EP1944288A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY30594A1 publication Critical patent/UY30594A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nuevos compuestos adecuados para ser marcados o ya marcados radioactivamente con 18F, métodos para preparar tales compuestos y uso de los mismo para diagnostico por imágenes.
UY30594A 2007-01-09 2007-09-14 Marcacion radioactiva por fluoracion de aziridinas UY30594A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07090001A EP1944288A1 (en) 2007-01-09 2007-01-09 Radiolabelling via fluorination of aziridines
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules

Publications (1)

Publication Number Publication Date
UY30594A1 true UY30594A1 (es) 2008-09-02

Family

ID=38941926

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30594A UY30594A1 (es) 2007-01-09 2007-09-14 Marcacion radioactiva por fluoracion de aziridinas

Country Status (24)

Country Link
US (1) US20090022664A1 (es)
EP (1) EP2099747A1 (es)
JP (1) JP2010522140A (es)
KR (1) KR20090096716A (es)
AR (1) AR062856A1 (es)
AU (1) AU2007343454A1 (es)
BR (1) BRPI0720884A2 (es)
CA (1) CA2674408A1 (es)
CL (1) CL2007002673A1 (es)
CO (1) CO6220852A2 (es)
CR (1) CR10917A (es)
DO (1) DOP2009000173A (es)
EC (1) ECSP099505A (es)
MA (1) MA31175B1 (es)
MX (1) MX2009007395A (es)
NO (1) NO20092813L (es)
PA (1) PA8747801A1 (es)
PE (1) PE20081661A1 (es)
RU (1) RU2009130455A (es)
SV (1) SV2009003328A (es)
TN (1) TN2009000233A1 (es)
TW (1) TW200829275A (es)
UY (1) UY30594A1 (es)
WO (1) WO2008083729A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784774B2 (en) 2011-09-16 2014-07-22 General Electric Company Labeled molecular imaging agents and methods of use
US9468692B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
US9468693B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
NL2014828B1 (en) * 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954994A (en) * 1968-10-03 1976-05-04 Pfizer Inc. Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents
JPS5810380B2 (ja) * 1975-01-31 1983-02-25 三共株式会社 ペプチドノ セイホウ
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
ES2340912T3 (es) * 1999-07-21 2010-06-11 The Trustees Of The University Of Pennsylvania Preparacion de compuestos utiles para la deteccion de hipoxia.
SE9903998D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
US6894057B2 (en) * 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
JP2006503008A (ja) * 2002-08-13 2006-01-26 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー マトリクスメタロプロテイナーゼ阻害物質としての４−ヒドロキシキノリン誘導体
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
CN1212307C (zh) * 2003-07-23 2005-07-27 中国科学院上海有机化学研究所 一种合成β－氟胺化合物的方法
EP1799637A1 (en) * 2004-09-23 2007-06-27 Amgen, Inc Substituted sulfonamidopropionamides and methods of use
WO2006110390A1 (en) * 2005-04-07 2006-10-19 Merck & Co., Inc. Mitotic kinesin inhibitors

Also Published As

Publication number Publication date
PA8747801A1 (es) 2009-08-26
CL2007002673A1 (es) 2008-07-18
WO2008083729A1 (en) 2008-07-17
RU2009130455A (ru) 2011-02-20
TN2009000233A1 (en) 2010-10-18
PE20081661A1 (es) 2009-01-18
BRPI0720884A2 (pt) 2014-03-25
SV2009003328A (es) 2009-12-14
CA2674408A1 (en) 2008-07-17
MA31175B1 (fr) 2010-02-01
JP2010522140A (ja) 2010-07-01
CO6220852A2 (es) 2010-11-19
TW200829275A (en) 2008-07-16
DOP2009000173A (es) 2010-10-31
AR062856A1 (es) 2008-12-10
NO20092813L (no) 2009-09-22
EP2099747A1 (en) 2009-09-16
KR20090096716A (ko) 2009-09-14
MX2009007395A (es) 2009-07-17
AU2007343454A1 (en) 2008-07-17
CR10917A (es) 2009-08-27
US20090022664A1 (en) 2009-01-22
ECSP099505A (es) 2009-08-28

Similar Documents

Publication Publication Date Title
CU20180033A7 (es) Conjugados de anticuerpo que comprenden un agonista del receptor tipo toll
ECSP099225A (es) Compuestos antagonistas del receptor de glucagón, composiciones que contienen dichos compuestos y procedimientos de uso
UY32037A (es) Daa-piridina
CL2016000883A1 (es) Compuestos macrocíclicos, inhibidores de antígeno prostático específico de membrana (psma); composición farmacéutica; complejo de metal; y su uso para preparar compuestos radiomarcados útiles para la formación de imágenes para diagnosticar y para el tratamiento de cáncer de próstata y/o metástasis de la misma.
UY30595A1 (es) Métodos de marcacion con fluor radioactivo
AR081750A1 (es) Anticuerpos anti-cd40
DOP2010000178A (es) Peptidil nitrilos como inhibidores de dipeptidil peptidasa i
CR20110421A (es) Agonistas y antagonistas del receptor de s1p, y métodos de uso de los mismos
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
HN2010001059A (es) Nuevo titulo modificado: compuestos derivados de pirimidina, un proceso para la preparacion de los mismos, una composicion farmaceutica que los comprenden y combinaciones de dichos compuestos con otros agentes.
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
AR090923A1 (es) Anticuerpos anti-il-23
CO6410315A2 (es) Nuevos anticuerpos anti-alfa5beta1 y sus usos
CL2009001686A1 (es) Procedimiento de preparacion de agomelatina; y los compuestos intermediarios considerados.
CR10654A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados
DE602006008639D1 (de) Automatisches radioaktives markierungsverafhren
UY30594A1 (es) Marcacion radioactiva por fluoracion de aziridinas
BR112022009471A2 (pt) Agentes de formação de imagem ativáveis por mieloperoxidase altamente eficientes
UY30801A1 (es) Compuestos calciliticos
UY30596A1 (es) Marcacion con fluor radioactivo
EA201100132A1 (ru) Единичная доза ападеносона
UY32290A (es) Derivados de lisina y ornitina marcados con radioisótopos, su uso y procesos para su preparación
CR9206A (es) Derivados de estilbeno y su uso para estudios de union y por imagenes de placas amiloides
CL2008001908A1 (es) Proceso para la preparación de 17alfa-(3-hidroxipropil)-17beta-hidroxiesteroides, los compuestos intermediarios usados en el proceso; y el proceso de preparación de dichos compuestos intermediarios.
DOP2009000036A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170724